ye-public-hai-sab-jaanti-hai
  1. You Are At:
  2. English News
  3. India
  4. Centre to buy 1 crore shots of Zydus Cadila's COVID vaccine at Rs 265 per dose

Centre to buy 1 crore shots of Zydus Cadila's COVID vaccine at Rs 265 per dose

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus, Zydus Cadila said.   

India TV News Desk Edited by: India TV News Desk
New Delhi Published on: November 08, 2021 18:05 IST
covid vaccine, covid 19 vaccine, zydus cadilla
Image Source : PTI

The three doses of ZyCoV-D, are to be administered 28 days apart. The vaccine was given emergency use authorization (EUA) by the Indian drug regulator on August 20, this year. The company has also sought approval for the two dose regimen of the vaccine.

 

The central government has placed an order of one crore doses of Zydus Cadila's three-dose COVID-19 vaccines, ZyCoV-D, at Rs 265 per dose, said the drug firm on Monday.

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the COVID-19 virus, Zydus Cadila said. 

The pricing has been decided in consultation with the central government, it added. The vaccine will be administered using a needle-free applicator as opposed to traditional syringes. The applicator, called "PharmaJet".

The PharmaJet is a needle free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.

"Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world’s first Plasmid DNA Vaccine, to the Government of India at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose, excluding GST," the pharma firm said in a regulatory filing

"We are happy to support the government's vaccination programme with ZyCoV-D. The needle-free application of the vaccination, we hope, will motivate many more to vaccinate and safeguard themselves from COVID-19, especially children and young adults in the age group of 12 to 18 years," Zydus Cadila MD Sharvil Patel said.

The vaccine has shown good stability at temperatures of around 25 degrees for at least three months. The thermostability of the vaccine will help in easy transportation and storage of the vaccine without any problems of fluctuations in temperature, it added. ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above.

The three doses of ZyCoV-D, are to be administered 28 days apart. The vaccine was given emergency use authorization (EUA) by the Indian drug regulator on August 20, this year. The company has also sought approval for the two dose regimen of the vaccine.

With PTI inputs

Also Read: Over 107.92 crore COVID vaccine doses administered so far in India

Also Read: Are COVID-19 boosters the same as the original vaccines?

Latest India News

Write a comment